RAF/MEK inhibitor
Advertisement
Dr. Camidge Discusses Launch of Phase 2 Trial Evaluating RAF/MEK Inhibitor in NSCLC
Kaitlyn D’OnofrioNon-Small Cell Lung Cancer | September 21, 2023
Verastem Oncology recently announced the initiation of the second phase 2 registration-directed clinical trial from its ...
View More
Drs. Banerji and Pachter Talk About RAF/MEK Inhibitor in RAS Mutant Tumors
Kaitlyn D’OnofrioOncology | April 28, 2023
Udai Banerji, Professor of Molecular Cancer Pharmacology at The Institute of Cancer Research, London, and Honorary ...
View More
Advertisement
Advertisement
Latest News

Gout Studies: Transplant Waitlisting and Bone Erosion

April 18, 2025

The Promise of Xenotransplantation

April 17, 2025

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

April 17, 2025

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    Contact Us

    eNewsletters

    Contribute

    Career Center

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |